ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer

Li, Weihua; Guo, Lei; Tang, Wanxiangfu; Ma, Yutong; Wang, Xiaonan; Shao, Yang; Zhao, Hong*; Ying, Jianming*中国医学科学院; 中国医学科学院北京协和医院
CLINICAL EPIGENETICS2021-12DOI: 10.1186/s13148-021-01108-3
19阅读
引用收藏
分享

摘要

Background Liver metastases can occur even in CRC patients who underwent curative surgery. While evidence suggested that adjuvant chemotherapy can help to reduce the occurrence of liver metastases for certain patients, it is not a recommended routine as the side effects outweigh the potential benefits, especially in Stage II CRC patients. This study aims to construct a model for predicting liver metastasis risk using differential methylation signals in primary CRC tumors, which can facilitate the decision for adjuvant chemotherapy. Methods Fifty-nine stage I/II and IV CRC patients were enrolled. Primary tumor, adjacent normal tissue, and metastatic tumor tissues were subject to targeted bisulfite sequencing for DNA methylation. The Least Absolute Shrinkage and Selection Operator (LASSO) algorithm was used to identify potential DMRs for predicting liver metastasis of CRC. Results We identified a total of 241,573 DMRs by comparing the DNA methylation profile of primary tumors of stage II patients who developed metastasis to those who were metastasis-free during the follow up period. 213 DMRs were associated with poor prognosis, among which 182 DMRS were found to be hypermethylated in the primary tumor of patients with metastases. Furthermore, by using the LASSO regression model, we identified 23 DMRs that contributed to a high probability of liver metastasis of CRC. The leave-one-out cross validation (LOOCV) was used to evaluate model predictive performance at an AUC of 0.701. In particular, 7 out of those 23 DMRs were found to be in the promoter region of genes that were previously reported prognostic biomarkers in diverse tumor types, including TNNI2, PAX8, GUF1, KLF4, EVI2B, CEP112, and long non-coding RNA AC011298. In addition, the model was also able to distinguish metastases of different sites (liver or lung) at an AUC of 0.933. Conclusion We have identified DNA methylation biomarkers associated with the risk of cancer liver metastasis in early-stage CRC patients. A risk prediction model based on those epigenetic markers was proposed for outcome assessment.

学科与关键词

关键词
Colorectal cancerLiver metastasisDMRsDNA methylationBiomarker
相关
加载中…
  • Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA
    Wang, Wei; Zhu, Xiaohui; Zhang, Xuecong; Lei, Chengyong; Zeng, Zhicheng; Lan, Xiaoliang; Cui, Wenzhi; Wang, Feifei; Xu, Shaowan; Zhou, Juan; Wu, Xuehui; Deng, Haijun; Li, Xia; Fan, Jianbing*; Ding, Yanqing*; Huang, Zhongxi*; Liang, Li*Journal of Pathology, 2023, 259(4): 376-387.被引 1
  • DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer
    Yu, Huichuan; Wang, Xiaolin; Bai, Liangliang; Tang, Guannan; Carter, Kelly T.; Cui, Ji; Huang, Pinzhu; Liang, Li; Ding, Yanqing; Cai, Muyan; Huang, Meijin; Liu, Huanliang; Cao, Guangwen; Gallinger, Steven; Pai, Rish K.; Buchanan, Daniel D.; Win, Aung Ko; Newcomb, Polly A.; Wang, Jianping; Grady, William M.; Luo, Yanxin*JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115(1): 52-61.被引 9
  • Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer
    Wang, Wei; Zhang, Xuecong; Zhu, Xiaohui; Cui, Wenzhi; Ye, Danli; Tong, Guihui; Huang, Dingpeng; Zhou, Juan; Lai, Xuwen; Yan, Guangning; Li, Xia; Fan, Jianbing*; Zhu, Hongwu*; Lei, Chengyong*Frontiers in Oncology, 2022, 12: 827811.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
CLINICAL EPIGENETICS
发表日期
2021-12
卷期
第 13 卷, 第 1 期
页码
126
DOI
10.1186/s13148-021-01108-3
成果收录
SCIE
资助标注
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81702436]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2019PT310026]; CAMS Innovation Fund for Medical Sciences [2017-I2M-1-006]; National Key Research and Development Program [2017YFC1311005]

作者

  • L

    Li, Weihua (第一作者)

    chinese acad med sci · peking union med coll

  • G

    Guo, Lei

    chinese acad med sci · peking union med coll

查看全部 8 位作者收起作者
  • T

    Tang, Wanxiangfu

  • M

    Ma, Yutong

  • W

    Wang, Xiaonan

  • S

    Shao, Yang

  • Z

    Zhao, Hong (通讯)

    chinese acad med sci · peking union med coll

  • Y

    Ying, Jianming (通讯)

    chinese acad med sci · peking union med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417